home All News open_in_new Full Article
Nuvation Bio (NYSE: NUVB) partner taletrectinib added to China's 2025 NRDL
today 6 h. ago attach_file Politics
attach_file
Politics
attach_file
Events
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Transport
attach_file
Politics
attach_file
Events
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
ID: 1048732972